• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Frontage Laboratories makes two senior appointments

Frontage Laboratories makes two senior appointments

July 18, 2013
CenterWatch Staff

George Laskaris and Alma Villasin have joined Frontage Laboratories in senior positions. Laskaris has been named senior director, Frontage Biometrics Services, and Villasin, R.N., B.S.N., M.B.A., joins as director, clinical operations.

Laskaris brings more than 20 years of programming, statistical and data management experience within pharmaceutical and CROs. He will spearhead operational management, infrastructure development and growth strategies for Frontage’s clinical programming, statistics and data management groups. Laskaris joins Frontage from PRA, where he managed a team of statistical programmers.

Villasin will be responsible for day-to-day oversight of clinical operations and staff training for all study activities and for oversight of the company’s clinical operations expansion initiative. Most recently, Villasin was clinical operations director for Duke Clinical Research Unit (DCRU), where she oversaw the feasibility and conduct of phase I-III clinical trials. Prior to DCRU, she worked at Thomas Jefferson University as manager of the clinical trials groups. She led a research collaboration on global cardiovascular phase II/III trials and developed an investigator network in key therapeutic areas such as cardiovascular, endocrinology and family medicine.

The addition of these two positions is part of Frontage’s strategy to expand its full-service early phase clinical services, which include capabilities to conduct a broad range of  studies  as well as broadening protocol development, analysis methodology and reporting services supporting later phase trials and programs.

Upcoming Events

  • 28Jun

    Effective Root Cause Analysis and CAPA Investigations for the Life Sciences

  • 16Oct

    WCG MAGI's Clinical Research Hybrid Conference - 2022 West

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • Protocol-360x240.png

    Avoid Deviations by Making Protocol Review a Team Effort

  • SelectionProcess-360x240.png

    Give Us a Voice: Sites Clamor for a Say on Vendor Selection

  • Convince-360x240.png

    Use Data and Details to Convince Site Leadership to Add Staff

  • AsktheExpertsBadge-360x240.png

    Ask the Experts: Listing Trial Staff and Others on the Statement of Investigator

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell My Personal Information

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2022. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing